Show simple item record

dc.contributor.authorZarei, S
dc.contributor.authorMohammad-Alizadeh-Charandabi, S
dc.contributor.authorMirghafourvand, M
dc.contributor.authorJavadzadeh, Y
dc.contributor.authorEffati-Daryani, F
dc.date.accessioned2018-08-26T08:52:59Z
dc.date.available2018-08-26T08:52:59Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53850
dc.description.abstractObjective. There is limited evidence on effectiveness of calcium and vitamin D on dysmenorrhea. The authors aimed to determine the effect of combined calcium-vitamin D and calcium-alone on pain intensity and menstrual blood loss in women with primary dysmenorrhea. Design. A randomized double-blind trial. Setting. Dormitories of Tabriz University of Medical Sciences. Subjects. 85 students with moderate or severe primary dysmenorrhea. Methods. Participants were randomized into three groups: receiving one tablet/day of 1000mg calcium+15000 IU vitamin D3, calcium-alone 1000 mg, or matched placebo, from 15th cycle day until menstrual pain disappearance in the following cycle, for three cycles. Pain intensity and menstrual blood lo(-7.7,-32.0 to 16.7)d one cycle before, three cycles under, and one cycle following intervention using 10-cm visual analog scale and pictorial blood loss assessment chart, respectively. The groups were compared using repeated measures ANOVA. Results. Time after intervention and interaction of time with group had no significant effects on the outcomes. Compared to the placebo group, mean pain intensity was lower in the both calcium-vitamin D (adjusted difference -0.7, 95% confidence interval -1.6 to 0.3) and calcium-alone (-1.6, -2.6 to -0.6) groups, but the difference was statistically significant only in the calcium-alone group. Menstrual blood loss was not significantly different in the either calcium-vitamin D (-4.7, -21.9 to 12.4) or calcium-alone (-0.4, -17.4 to 16.4) groups compared to placebo. Conclusions. Intake of the calcium-alone was effective in reducing menstrual pain intensity. The results could not indicate significant effects of calcium-vitamin D on the pain or any of the interventions on menstrual blood loss. Clinical trial registration. This study was approved by the Ethics committee of Tabriz University of Medical Sciences (code 92145) and registered at the Iranian Registry of Clinical Trials with IRCT201402043706N21. ï?½ 2016 American Academy of Pain Medicine. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofPain Medicine (United States)
dc.subjectcalcium
dc.subjectcolecalciferol
dc.subjectplacebo
dc.subjectcalcium
dc.subjectcolecalciferol
dc.subjectadult
dc.subjectanalgesia
dc.subjectArticle
dc.subjectcombination drug therapy
dc.subjectcontrolled study
dc.subjectdrug efficacy
dc.subjectdysmenorrhea
dc.subjectfemale
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmenstruation
dc.subjectmonotherapy
dc.subjectpain intensity
dc.subjectpain severity
dc.subjectrandomized controlled trial
dc.subjectvisual analog scale
dc.subjectadolescent
dc.subjectdouble blind procedure
dc.subjectdrug effects
dc.subjectdysmenorrhea
dc.subjectmenstruation
dc.subjectpain
dc.subjectyoung adult
dc.subjectAdolescent
dc.subjectAdult
dc.subjectCalcium
dc.subjectCholecalciferol
dc.subjectDouble-Blind Method
dc.subjectDysmenorrhea
dc.subjectFemale
dc.subjectHumans
dc.subjectMenstruation
dc.subjectPain
dc.subjectYoung Adult
dc.titleEffects of calcium-vitamin D and calcium alone on pain intensity and menstrual blood loss in women with primary dysmenorrhea: A randomized controlled trial
dc.typeArticle
dc.citation.volume18
dc.citation.issue1
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1093/pm/pnw121


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record